TMDX insider trading
NasdaqGM HealthcareTransMedics Group, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About TransMedics Group, Inc.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Company website: www.transmedics.com
TMDX insider activity at a glance
FilingIQ has scored 741 insider transactions for TMDX since May 6, 2019. The most recent filing in our index is dated Mar 4, 2026.
Across the full history, 10 open-market purchases
and 422 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TMDX insider trades is 63.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TMDX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding TMDX
Frequently asked
- How many insider trades does FilingIQ track for TMDX?
- FilingIQ tracks 741 Form 4 insider transactions for TMDX (TransMedics Group, Inc.), covering filings from May 6, 2019 onwards. 14 of those were filed in the last 90 days.
- Are TMDX insiders net buyers or net sellers?
- Across the full Form 4 history for TMDX, 10 transactions (1%) were open-market purchases and 422 (57%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TMDX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is TMDX in?
- TransMedics Group, Inc. (TMDX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $4.59B.
Methodology & sources
Every TMDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.